Non-alcoholic fatty liver diseases (NAFLDs) are one of the principal causes of abnormal ALT levels [7], which are exacerbated by obesity, diabetes, and hyperlipidemia [8]. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.